Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Myocardial Ischemia » Angina Pectoris
Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Myocardial Ischemia » Angina Pectoris
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Pain » Chest Pain » Angina Pectoris
Description
The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. MeSH
Hierarchy View
Subtype Terms (3)
Angina, Stable
79 drugs (42 approved, 37 experimental)
Angina, Unstable
54 drugs (37 approved, 17 experimental)
Microvascular Angina
21 drugs (14 approved, 7 experimental)
Approved Indicated Drugs (33)
Phase 4 Indicated Drugs (32)
Phase 2 Indicated Drugs (16)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (87)
Ada and Hagbart Waages Humanitarian and Charity Foundation
Alf and Aagot Helgesens Research Foundation
Beijing Duheng for Drug Evaluation and Research Co., Ltd. (DDER)
Burnasyan Federal Medical Biophysical Center
Cardiovascular Consultants of Nevada
CardioVascular Research Foundation, Korea
China Academy of Chinese Medical Sciences
China Food and Drug Administration
First Hospital of Shijiazhuang City
Fundação Educacional Serra dos Órgãos
Guangdong Provincial Hospital of Traditional Chinese Medicine
Huazhong University of Science and Technology
IHF GmbH - Institut für Herzinfarktforschung
Imam Abdulrahman Bin Faisal University
Jiangsu Kangyuan Pharmaceutical Co. Ltd
Liaoning Hospital of Traditional Chinese Medicine
Luohe Hospital of Traditional Chinese Medicine
Mashhad University of Medical Sciences
Mochida Pharmaceutical Company, Ltd.
National Natural Science Foundation of China
Nicolaus Copernicus University
Nova Scotia Health Research Foundation
People's Liberation Army of China
Shaanxi Buchang Pharmaceutical Co., Ltd
Organization Involved with Phase 3 Indications (32)
Organization Involved with Phase 2 Indications (34)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (10)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
